Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clare Hollingsworth joins Assura's board of directors

This article was originally published in Scrip

Executive Summary

Assura, a UK healthcare company partnering with GPs to deliver high-quality patient care in the community, property solutions and consumer-responsive pharmacy services, has appointed Clare Hollingsworth to the board as a non-executive director. She will replace Fred Porter, who has announced his intention to stand down from the board with effect from the company’s 2008 annual general meeting on August 6th. Ms Hollingsworth is non-executive deputy chairman and former chief executive of Spire Healthcare, a company which was formed in 2007 from the sale of BUPA hospitals to the private equity company Cinven.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC003928

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel